Skip to main content
Premium Trial:

Request an Annual Quote

Predicine, Flagship Biosciences to Provide Combined Service

NEW YORK (GenomeWeb) – Predicine and Flagship Biosciences said Thursday that they have agreed to enter a strategic venture, which will combine Predicine's GeneRADAR molecular insights platform with Flagship's artificial intelligence-enabled cTA digital pathology platform for pharmaceutical customers in the immuno-oncology space.

The two companies said they will work together to provide an integrated molecular and contextual tissue biomarker solution. Predicine's GeneRADAR is a combined liquid biopsy assay for both circulating tumor DNA and circulating RNA targets. Flagship offers computational tissue imaging analysis for biomarker detection.

Predicine Founder and CEO Shidong Jia said in a statement that the partnership represents a furtherance of Predicine's goal to provide a comprehensive blood- and tissue-based biomarker profiling in support of global clinical trials. The company is based in Hayward, California.

The agreement also represents an expansion of Flagship's global footprint, with the Westminster, Colorado-based firm's technology now available through Predicine's CAP-accredited laboratories in China.

Financial and other terms of the deal were not disclosed.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.